Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.625p +2.49% 25.75p 25.00p 26.50p 26.25p 25.00p 25.00p 2,221,160 16:35:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 38.6 -1.0 0.0 - 119.55

Ekf Diagnostics Share Discussion Threads

Showing 1426 to 1448 of 1450 messages
Chat Pages: 58  57  56  55  54  53  52  51  50  49  48  47  Older
DateSubjectAuthorDiscuss
18/10/2017
11:35
MW...Sorry to learn that. HbA1c can be used as a diagnostic test for diabetes and as a screening test for people at high risk of diabetes. But it is also a very important test for people managing diabetes, as any reduction in HbA1c levels will have beneficial effects with regard to reducing the risk of developing complications (nerve damage, eye disease, kidney disease and heart disease). One thing that I have always thought regarding type 1 diabetes, is that should there be a medical breakthrough preventing individuals from having to inject insulin (and thereby not having to regularly check/test glucose levels), regular HbA1c testing is very likely to still be recommended.
wan
18/10/2017
11:10
wan your post accords with my own experience, fasting blood glucose was all right just when I was diagnosed but HbA1c was clearly abnormal as was the glucose tolerance test, though one can't extrapolate from n=1!
mw8156
18/10/2017
11:04
9degrees...Yes I did note that, however, 60% of the world's diabetic population is Asian, so despite the limitations of the study from a global perspective, the findings are still relevant. It's an unfortunate fact that Asians are far more likely to develop diabetes compared with people from white European backgrounds. China has the largest diabetic population in the world, followed by India, the US is a distant 3rd! Why are Asians at Higher Risk? Studies have shown that Asians are at higher risk of developing type 2 diabetes, when compared with people of European ancestry.1 Asians are more likely to develop the disease even at a lower BMI. This means that even though some Asian populations currently have a lower prevalence of overweight and obese individuals than populations in the West, they have a disproportionately high percentage of people with diabetes.1 Currently, 60% of the world’s diabetic population is Asian. hxxp://asiandiabetesprevention.org/what-is-diabetes/why-are-asians-higher-risk
wan
18/10/2017
11:04
Double post!
wan
18/10/2017
10:39
Wan - all people tested were Vietnamese - not a typical western diet and lifestyle I wonder if that makes a difference ??
9degrees
18/10/2017
08:32
I noted the following recently - October 06, 2017 HbA1c vs Fasting Plasma Glucose for Prediabetes, Diabetes Diagnosis Patients with undiagnosed diabetes screened via fasting plasma glucose (FPG) may remain undiagnosed vs patients screened via hemoglobin A1c (HbA1c) blood test, according to a study published in PLOS ONE. The investigators concluded that HbA1c testing has a higher sensitivity for identifying patients at risk for diabetes vs FPG, and therefore may have a greater impact on the diagnoses, cost, burden, and treatment of patients with diabetes. Full story - https://tinyurl.com/HbA1c-testing
wan
14/10/2017
07:07
Ortho Clinical, EKF Expand Access to Ketoacidosis Assay Oct 11, 2017 NEW YORK – Ortho Clinical Diagnostics and EKF Diagnostic today announced a deal to provide patients expanded access to EKF's beta-hydroxybutyrate assay for the diagnosis of ketoacidosis. Full story - https://tinyurl.com/ortho-clinical-ekf-diagnostics
wan
11/9/2017
08:01
Excellent progress still being made, and given the 'long' list of new product registrations being pursued (amongst other things), it would appear there is a lot more growth and progress to come!
wan
09/8/2017
19:08
charts still indicate more upside
sirshagalot
07/8/2017
11:35
zwanzigger reduced his holdings
9degrees
18/7/2017
12:34
Kestelmill - I agree re the acquisition de-focus. However, just to qualify that - the only failed acquisition (out of 8) was Selah. This failed because the management team was not experienced enough (and arguably the industry was not ready) to move into molecular diagnostics alongside traditional point of care diagnostics.
tawnyport
18/7/2017
12:29
I would hardly classify a new NED as a new team. Anyway, the crux here is that a new non-exec Chairman is in place and he is an experienced, focussed, and successful individual - he is the one who has given the company a new lease of life by concentrating on an exit-based trade sale strategy, one which the previous Chairman arguably was unable to consummate.
tawnyport
18/7/2017
12:15
So we have more than just one new team member, arguably a different team, and perhaps most importantly, a new focus.
wan
18/7/2017
11:56
Wan - Julian Baines has been there as CEO since the Company listed in 2010; Richard Evans has been COO/CFO (and previously just CFO) since 2011. Adam has been an NED since 2010 and Carl was appointed an NED earlier this year.
tawnyport
18/7/2017
11:36
Tawnyport...I suggest you check the RNS announcements then, along with the following EKF investor page - hxxps://www.ekfdiagnostics.com/investors-directors-advisors.html
wan
18/7/2017
11:17
Wan - the only new management team member is Chris Mills; he replaced David Evans (who was succeeded by Ron Zwanziger for a short period).
tawnyport
17/7/2017
16:25
Large volume today!
wan
06/7/2017
17:04
Kestlemill...No it's not the same management team you refer to. EKF have a new management team in place, it has been restructured, refocused and refinanced, hence the significant improvements that are now flowing through.
wan
06/7/2017
16:48
Don't want to rain on your parade Wan - things are on the up - but isn't this the same management team who bought Selah Genomics for USD 35.6M plus milestone payments then less than two years later gave it back to Selah for nothing and wrote down GBP 41M off EKF's balance sheet?
kestelmill
06/7/2017
15:55
It has taken a long time but finally things are moving in the right direction. Well done. Let's just hope that the cash being generated doen't burn a hole in the management's pockets so that are tempted to make another disastrous (American) acquisition.
interstellar
06/7/2017
09:13
It is likely that the investments in consumable capacity expansion in Germany and replacement of equipment in the US (mentioned in 2016), are starting to be felt. One assumes then that these investments, apart from targeting possible costs savings/increased margins, were in light of increased orders and will also support tenders for new contracts. I note that in 2016 EKF had a particularly strong 3rd quarter (July - Sept), so hopefully the momentum currently being experienced continues and obviously even better if it accelerates!
wan
08/6/2017
17:57
odd 1 million shares just slipped through LATE TRADE AT 21.5P
9degrees
11/5/2017
11:27
Having just read EKF's AR, some ingredients look set to further improve the financials in 2017. This has now been borne out by the most recent trading update for the first quarter where it was good to see that the Board remain optimistic about the Company's prospects for the full year. The impressive and growing installed base of POC instruments provides for an excellent recurring revenue model(razor/razor-blade model). Given the stable and predictable revenues from such a business model, and given plans to spin-off the Lab Diagnostics business (which will create value) along with a potential share buy back, does this imply that EKF might be looking at becoming a high paying dividend stock in the not too distant future? Or will the pure focus on POC diagnostics put EKF back in play as a take-over target (at a much higher premium than previous bids)? Either way, the future appears to look very promising!
wan
Chat Pages: 58  57  56  55  54  53  52  51  50  49  48  47  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20171021 02:52:40